Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-01 Purchase |
2021-06-02 4:37 pm |
Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER |
490 | $2.93 | $1,436 | 1,016,098 (Indirect) |
View |
| 2021-05-25 Purchase |
2021-05-28 6:49 pm |
Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER |
602 | $2.4876 | $1,498 | 2,031,031 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-11-08 Option Award |
2023-11-13 4:30 pm |
N/A 2033-11-08 |
Aditxt Inc. | ADTX | Shabahang Shahrokh Chief Innovation Officer |
7,053 | $0 | 7,053 (Direct) |
View |
| 2021-07-22 Option Award |
2021-11-12 9:50 pm |
N/A N/A |
Aditxt Inc. | ADTX | Shabahang Shahrokh Chief Innovation Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2021-03-17 Exercise |
2021-03-22 4:16 pm |
2018-03-17 2021-03-17 |
Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER |
18,750 | $0 | 1,015,006 (Indirect) |
View |
| 2021-03-17 Exercise |
2021-03-22 4:16 pm |
N/A N/A |
Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER |
18,750 | $4 | 1,015,006 (Indirect) |
View |
| 2020-11-02 Option Award |
2020-11-04 9:20 pm |
N/A 2030-11-02 |
ADiTx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER |
110,000 | $0 | 110,000 (Direct) |
View |
| 2020-07-24 Exercise |
2020-08-03 8:27 pm |
2020-07-02 2025-06-29 |
ADiTx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER |
47,222 | $11.25 | 996,256 (Indirect) |
View |
Ownership |
2020-07-09 9:17 pm |
N/A N/A |
ADiTx Therapeutics Inc. | Shabahang Shahrokh CHIEF INNOVATION OFFICER |
0 | $0 | 1,235,159 (Indirect) |
View |